In the highly regulated pharmaceutical industry, the purity of every chemical compound used in drug synthesis is of utmost importance. Benzyl octahydrocyclopenta[b]pyrrole-2-carboxylate, a key intermediate in the production of Ramipril, is no exception. Manufacturers must ensure they obtain this compound from reputable suppliers who guarantee a high assay, such as the ≥98.0% typically provided. NINGBO INNO PHARMCHEM CO.,LTD., a prominent chemical manufacturer in China, is recognized for its dedication to upholding these stringent quality standards.

The physical characteristics of Benzyl octahydrocyclopenta[b]pyrrole-2-carboxylate, notably its appearance as a white to off-white powder, are indicators of its quality and suitability for pharmaceutical applications. Its molecular formula (C15H19NO2) and molecular weight (245.317) are precise identifiers that researchers and procurement specialists use when looking to buy this intermediate. Identifying the correct CAS number, 93779-31-8, is the first step in ensuring that the material procured is indeed the intended compound for Ramipril synthesis.

NINGBO INNO PHARMCHEM CO.,LTD. understands the critical nature of these specifications. As a leading supplier, they prioritize robust quality control measures throughout their manufacturing process. This commitment ensures that their Benzyl octahydrocyclopenta[b]pyrrole-2-carboxylate is consistently pure, reliable, and compliant with the requirements for pharmaceutical manufacturing. The availability of this intermediate in suitable packaging and quantities further supports efficient production cycles for their clients.

For companies engaged in the development and manufacturing of ACE inhibitors, securing a consistent and high-quality supply of essential intermediates is vital. NINGBO INNO PHARMCHEM CO.,LTD.'s reputation as a reliable manufacturer and supplier in China makes them a preferred partner. Their ability to provide the necessary documentation and support, coupled with competitive pricing, solidifies their role in facilitating the production of vital medications that improve patient health.